Quantum Healthcare Ltd. (V8Y) AI Stock Analysis

• Market Cap: S$10.74M
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): -3.85
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: SG
• Employees: 87
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 0.00
• Shares Outstanding: 10,741,773,000
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: 0.18
• Price to Book (P/B): -4.40
• Price to Sales (P/S): 1.25
• P/FCF Ratio: 14.51
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 38 Underperform
• Price Target: ―

The overall stock score is primarily driven by financial performance concerns, including profitability issues and financial instability. The lack of technical analysis data further limits the assessment.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust demand for Quantum Healthcare's products and services, suggesting a solid market position and potential for future expansion.

Strategic Capital Restructuring

The strategic issuance of new shares and debt conversion aims to strengthen the company's capital structure, enhancing financial stability and flexibility.

Innovative Business Model

The company's focus on innovation in healthcare technology positions it well to capitalize on industry trends and drive long-term growth.

Negative Factors

Profitability Challenges

Ongoing profitability issues may hinder Quantum Healthcare's ability to reinvest in growth and innovation, affecting long-term sustainability.

High Leverage

High leverage and negative equity suggest financial instability, which could limit the company's operational flexibility and increase risk.

Cash Flow Management Issues

Negative free cash flow growth indicates challenges in cash management, potentially impacting the company's ability to fund operations and growth initiatives.

Quantum Healthcare Ltd. Business Overview & Revenue Model

Company Description

Quantum Healthcare Ltd. (V8Y) is a forward-thinking company at the forefront of the healthcare technology sector, specializing in innovative solutions that enhance patient care and streamline healthcare operations. The company focuses on developing advanced medical devices, integrated health management systems, and data analytics platforms aimed at improving clinical outcomes and operational efficiency across hospitals and clinics. With a commitment to harnessing the power of quantum computing and artificial intelligence, Quantum Healthcare aims to revolutionize how healthcare providers deliver services to patients.

How the Company Makes Money

Quantum Healthcare Ltd. generates revenue through multiple streams, primarily by selling its proprietary medical devices and software solutions to healthcare institutions, including hospitals and outpatient clinics. The company also offers subscription-based access to its health management platforms, which provide ongoing support and updates to clients. Additionally, Quantum Healthcare engages in strategic partnerships with pharmaceutical companies and research institutions, collaborating on projects that leverage its technology for drug development and clinical research, which can yield significant funding and shared revenue opportunities. Furthermore, the company may receive grants and funding from government and private organizations aimed at promoting healthcare innovation, contributing to its overall earnings.

Quantum Healthcare Ltd. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	12.94M	12.69M	13.08M	9.37M	0.00
Gross Profit	5.87M	5.66M	5.76M	4.35M	-246.00K
EBITDA	249.00K	-318.00K	-1.45M	-7.23M	-5.03M
Net Income	-1.83M	-2.23M	-3.62M	-9.07M	-5.28M
Balance Sheet
Total Assets	11.55M	12.53M	13.03M	14.45M	916.00K
Cash, Cash Equivalents and Short-Term Investments	199.00K	386.00K	744.00K	5.07M	344.00K
Total Debt	6.86M	7.64M	6.51M	7.55M	997.00K
Total Liabilities	14.93M	15.50M	16.06M	15.35M	3.55M
Stockholders Equity	-3.96M	-3.62M	-3.87M	-1.50M	-2.59M
Cash Flow
Free Cash Flow	1.12M	1.09M	-926.00K	-2.23M	-1.30M
Operating Cash Flow	1.40M	1.45M	-628.00K	-1.30M	-1.30M
Investing Cash Flow	387.00K	-1.07M	-3.42M	-5.04M	81.00K
Financing Cash Flow	-1.88M	-733.00K	-272.00K	11.06M	240.00K

Quantum Healthcare Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
V8Y	38 Underperform	S$10.74M	―	―	―	―	―

Quantum Healthcare Ltd. Corporate Events

Quantum Healthcare Ltd. Secures SGX-ST Listing Approval for Strategic Share Issuance

Quantum Healthcare Ltd. has received a listing and quotation notice from the SGX-ST for the proposed placement of new ordinary shares, conversion of debt into shares, and capitalisation of directors’ fees into shares. This development is contingent upon compliance with SGX-ST’s listing requirements and shareholder approval. The announcement signifies a strategic move to restructure the company’s capital and address outstanding financial obligations, potentially impacting its financial stability and market positioning.

Quantum Healthcare Delays Share Placement, Extends Completion Date

Quantum Healthcare Ltd. announced a delay in its proposed placement of new ordinary shares due to incomplete administrative processes and the need for additional due diligence by the placees. The company has entered into a supplemental agreement to extend the completion date for the placement to November 30, 2025, indicating a strategic move to ensure compliance and successful execution of its financial plans.

Quantum Healthcare Secures SGX-ST Approval for Share Listing

Quantum Healthcare Ltd. has received approval from the SGX-ST for the listing and quotation of new ordinary shares related to a proposed placement, debt conversion, and directors’ fees capitalization. This development is contingent upon compliance with listing requirements and shareholder approval. The move is part of the company’s strategy to strengthen its capital structure and improve financial flexibility, potentially impacting its market positioning and stakeholder interests.

Quantum Healthcare Ltd. Capitalizes Directors’ Fees to Issue New Shares

Quantum Healthcare Ltd. has announced an agreement to capitalize part of the outstanding director’s fees owed to Mr. Sho Kian Hin, a former independent director. The company will issue 58,157,091 new shares to Mr. Sho at a premium price to settle S$63,972.80 of the fees, leaving a balance of S$15,993.20. This move reflects the company’s strategic financial management and aims to maintain shareholder value by considering potential dilution and aligning with previous capitalisation terms.